Approval of a 3D-printed drug opens up a new world of customised medication, but also the possibility of counterfeit drugs, mislabelling and a regulatory vacuum

The prospect of tailor-made drugs that are customised to your individual needs has moved a step closer with the recent announcement of the first 3D-printed (3DP) drug to gain approval from the US food and drug administration (FDA).

Related: Smile! Meet the 3D printer churning out teeth, nerves and gums for dentists

Continue reading…
Source: The Guardian Circular Economy RSS